well, it's a really important decision for the uk. the expert committee, thejoint committee on vaccination and immunisation, independent, was asked to say what are the benefits and risks of vaccinations for i2—to—15—year—olds. and they have come up with a rather qualified conclusion, which is that the health benefits marginally outweigh the risks, but they are not going to go any further than that. in the past, they have given the thumbs up to 16 and i7—year—olds and other groups before that. so the result of that is that the uk's chief medical officer will now have to draw up their guidelines for parents and families in different parts of the uk. so, a rather a strange outturn there, given that in the us, for example, france and canada, they've gone ahead with injecting i2—year—olds a little while ago. so it shows that there's still quite a lively debate on whether it is a good idea. and about effectiveness. i want to come back to the question of further doses for people who have been